WHO ICTRP trial

The IPa-Gastric trial: Comparing Intraperitoneal Paclitaxel and Systemic Therapy…

CTIS2024-514879-17-00 · EU Clinical Trials Information System · Recruiting

Key facts

Trial ID CTIS2024-514879-17-00
Public title The IPa-Gastric trial: Comparing Intraperitoneal Paclitaxel and Systemic Therapy versus Systemic Therapy alone in Gastric Cancer Patients with Peritoneal Metastasis
Scientific title Randomised Phase III Trial of First Line Intraperitoneal Paclitaxel and Systemic Therapy versus Systemic Therapy Alone in Gastric Cancer Patients with Peritoneal Metastases - IPa-Gastric 1.0
Primary sponsor Karolinska University Hospital
Registry EU Clinical Trials Information System
Recruitment status Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): Yes Therapeutic use - (Phase IV): No
Countries United Kingdom;Switzerland;Italy;Netherlands;Norway;Sweden
Conditions Gastric cancer MedDRA version: 27.0Level: PTClassification code: 10063916Term: Metastatic gastric cancer Class: 100000004864;Therapeutic area: Diseases [C] - Neoplasms [C04]
Interventions Product Name: , Product Code:SCP8265340, Pharmaceutical Form: , Other descriptive name: , Strength: , Product Name: , Product Code:SCP131876, Pharmaceutical Form: , Other descriptive name: , Strength: , Product Name: , Product…
Registration date Apr 17, 2025
Target size 146
Registry page euclinicaltrials.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations